Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.57% | 183.82 | 1.3% | $480.29m | |
| ARRY | Array BioPharma Inc. | 0.13% | 46.56 | 8.1% | $427.04m | |
| CELG | Celgene Corporation | 0.36% | 98.18 | 1.3% | $407.50m | |
| GILD | Gilead Sciences, Inc. | 0.37% | 68.51 | 0.9% | $394.96m | |
| BIIB | Biogen Inc. | 0.58% | 235.25 | 1.3% | $352.72m | |
| ILMN | Illumina, Inc. | 1.37% | 356.76 | 3.5% | $286.08m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 3.15% | 320.62 | 2.6% | $240.74m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.67% | 182.96 | 1.9% | $218.15m | |
| A | Agilent Technologies, Inc. | 0.20% | 72.79 | 1.6% | $195.60m | |
| EXAS | Exact Sciences Corporation | -0.63% | 115.26 | 24.1% | $187.97m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 3.64% | 128.28 | 2.0% | $184.46m | |
| BMRN | BioMarin Pharmaceutical Inc. | 1.51% | 86.30 | 4.3% | $129.76m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.67% | 130.83 | 14.7% | $109.38m | |
| INCY | Incyte Corporation | 2.05% | 86.61 | 2.5% | $108.62m | |
| MRTX | Mirati Therapeutics Inc. | 3.41% | 104.68 | 2.5% | $101.75m |
Company Profile
Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF), and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA.